Clinical Trial Update: Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial studies Gemcitabine/Carboplatin as first-line therapy with or without Apatorsen in advanced squamous cell carcinoma of the lung.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Apatorsen (apatorsen)
• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Queen Mary University of London | Conditions: Squamous Cell Lung Cancer | Phase 2 | Status: UNKNOWN